Overview of approved compassionate use programmes

The MEB can give permission for bringing a medicinal product on the market that has not (yet) been granted a marketing authorisation, known as a compassionate use programme. A company can make this medicinal product available to the patient group. The overview lists all the approved compassionate use programmes including the indication and the duration.

Overview of approved compassionate use programmes

2019

2018

2017

2016

2015

2014

2013

2010